The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: Lessons from the Friend virus model

Virology

Volumn 272, Issue 2, 2000, Pages 244-249

  Hasenkrug, Kim J ^a   Dittmer, Ulf ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CYTOTOXIC T LYMPHOCYTE; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SHORT SURVEY; SPLENOMEGALY; T LYMPHOCYTE SUBPOPULATION; VIREMIA; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 0034608958     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0387     Document Type: Article

References (38)

1. Beekman N. J., van Veelen P. A., van Hall T., Neisig A., Sijts A., Camps M., Kloetzel P. M., Neefjes J. J., Melief C. J., Ossendorp F. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J. Immunol. 164:2000;1898-1905.
2. Brander C., Walker B. D. T lymphocyte responses in HIV-1 infection: Implications for vaccine development. Curr. Opin. Immunol. 11:1999;451-459.
3. Britt W. J., Chesebro B. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia. J. Immunol. 130:1983;2363-2367.
4. Chen W., Qin H., Chesebro B., Cheever M. A. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J. Virol. 70:1996;7773-7782.
5. Chesebro B., Bloom M., Wehrly K., Nishio J. Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia. J. Virol. 32:1979;832-837.
6. Chesebro B., Miyazawa M., Britt W. J. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu. Rev. Immunol. 8:1990;477-499.
7. Chesebro B., Wehrly K. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA. 76:1979;425-429.
8. Chesebro B., Wehrly K., Stimpfling J. Host genetic control of recovery from Friend leukemia virus-induced splenomegaly. Mapping of a gene within the major histocompatibility complex. J. Exp. Med. 140:1974;1457-1467.
9. Dittmer U., Brooks D. M., Hasenkrug K. J. Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J. Virol. 72:1998;6554-6558.
10. Dittmer U., Brooks D. M., Hasenkrug K. J. Protection against establishment of retroviral persistence by vaccination with a live attenuated virus. J. Virol. 73:1999a.
11. Dittmer U., Brooks D. M., Hasenkrug K. J. Requirement for multiple lymphocyte subsets in protection against retroviral infection by a live attenuated vaccine. Nat. Med. 5:1999b;189-193.
12. Dittmer U., Hasenkrug K. J. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections. Virology. 272:2000;177-182.
13. Dittmer U., Hunsmann G. Long-term non-progressive human immunodeficiency virus infection: New insights from the simian immunodeficiency virus model. J. Gen. Virol. 78:1997;979-984.
14. Dittmer U., Race B., Hasenkrug K. J. Kinetics of the development of protective immunity in mice vaccinated with a live-attenuated retrovirus. J. Virol. 73:1999c;8435-8440.
15. Furci L., Scarlatti G., Burastero S., Tambussi G., Colognesi C., Quillent C., Longhi R., Loverro P., Borgonovo B., Gaffi D., Carrow E., Malnati M., Lusso P., Siccardi A. G., Lazzarin A., Beretta A. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J. Exp. Med. 186:1997;455-460.
16. Haigwood N. L., Watson A., Sutton W. F., McClure J., Lewis A., Ranchalis J., Travis B., Voss G., Letvin N. L., Hu S. L., Hirsch V. M., Johnson P. R. Passive immune globulin therapy in the SIV/macaque model: Early intervention can alter disease profile. Immunol. Lett. 51:1996;107-114.
17. Hasenkrug K. J. Lymphocyte deficiencies increase susceptibility to Friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. J. Virol. 73:1999;6468-6473.
18. Hasenkrug K. J., Brooks D. M., Chesebro B. Passive immunotherapy for retroviral disease: Influence of major histocompatibility complex type and T-cell responsiveness. Proc. Natl. Acad. Sci. USA. 92:1995;10492-10495.
19. Hasenkrug K. J., Brooks D. M., Dittmer U. Critical role for CD4+ T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72:1998;6559-6564.
20. Hasenkrug K. J., Chesebro B. Immunity to retroviral infection: The Friend virus model. Proc. Natl. Acad. Sci. USA. 94:1997;7811-7816.
21. Hasenkrug K. J., Sprangrude G. J., Nishio J., Brooks D. M., Chesebro B. Recovery from Friend disease in mice with reduced major histocompatibility complex class I expression. J. Virol. 68:1994;2059-2064.
22. Hom R. C., Finberg R. W., Mullaney S., Ruprecht R. M. Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells. J. Virol. 65:1991;220-224.
23. Iwashiro M., Kondo T., Shimizu T., Yamagishi H., Takahashi K., Matsubayashi Y., Masuda T., Otaka A., Fujii N., Ishimoto A., Miyazawa M., Robertson M. J., Chesebro B., Kuribayashi K. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J. Virol. 67:1993;4533-4542.
24. Jin X., Bauer D. E., Tuttleton S. E., Lewin S., Gettie A., Blanchard J., Irwin C. E., Safrit J. T., Mittler J., Weinberger L., Kostrikis L. G., Zhang L., Perelson A. S., Ho D. D. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:1999;991-998.
25. Kalams S. A., Buchbinder S. P., Rosenberg E. S., Billingsley J. M., Colbert D. S., Jones N. G., Shea A. K., Trocha A. K., Walker B. D. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J. Virol. 73:1999;6715-6720.
26. LaCasse R. A., Follis K. E., Trahey M., Scarborough J. D., Littman D. R., Nunberg J. H. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV [see comments]. Science. 283:1999;357-362.
27. Michael N. L., Brown A. E., Voigt R. F., Frankel S. S., Mascola J. R., Brothers K. S., Louder M., Birx D. L., Cassol S. A. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection - Evidence for highly susceptible human hosts. J. Infect. Dis. 175:1997;1352-1359.
28. Miyazawa M., Nishio J., Wehrly K., Jay G., Melvoid R. W., Chesebro B. Detailed mapping of the Rfv-1 gene that influences spontaneous recovery from Friend retrovirus-induced leukaemia. Eur. J. Immunogenet. 19:1992;159-164.
29. Ossendorp F., Eggers M., Neisig A., Ruppert T., Groettrup M., Sijts A., Mengede E., Kloetzel P. M., Neefjes J., Koszinowski U., Melief C. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:1996;115-124.
30. Parren P. W. H. I., Moore J. P., Burton D. R., Sattentau Q. J. The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity. AIDS. 13:1999;S137-S162.
31. Persons D. A., Paulson R. F., Loyd M. R., Herley M. T., Bodner S. M., Bernstein A., Correll P. H., Ney P. A. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase [see comments]. Nat. Genet. 23:1999;159-165.
32. Peterson K. E., Iwashiro M., Hasenkrug K. J., Chesebro B. MHC class I gene controls the generation interferon gamma-producing CD4+ and CD8+ T cells important for recovery from Friend retrovirus-induced leukemia. J. Virol. 2000.
33. Robertson M. N., Spangrude G. J., Hasenkrug K., Perry L., Nishio J., Wehrly K., Chesebro B. Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. J. Virol. 66:1992;3271-3277.
34. Rosenberg E. S., Billingsley J. M., Caliendo A. M., Boswell S. L., Sax P. E., Kalams S. A., Walker B. D. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia [see comments]. Science. 278:1997;1447-1450.
35. Ruan K. S., Lilly F. Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes. Virology. 181:1991;91-100.
36. Schmitz J. E., Kuroda M. J., Santra S., Sasseville V. G., Simon M. A., Lifton M. A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B. J., Ghrayeb J., Forman M. A., Montefiori D. C., Rieber E. P., Letvin N. L., Reimann K. A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283:1999;857-860.
37. Super H. J., Brooks D., Hasenkrug K. J., Chesebro B. Requirement for CD4+ T cells in the Friend murine retrovirus neutralizing antibody response: Evidence for functional T cells in genetic low-recovery mice. J. Virol. 72:1998;9400-9403.
38. Uenishi H., Iwanami N., Kuribayashi K., Tamamura H., Fujii N., Nakatani T., Kawasaki T., Yamagishi H. Overlapping epitopes of Friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T-lymphocyte clones. Immunol. Lett. 62:1998;33-38.